{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:52:20Z","timestamp":1780372340976,"version":"3.54.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["01120496"],"award-info":[{"award-number":["01120496"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>PsA patients who achieved sustained minimal disease activity (sMDA) had less subclinical atherosclerosis progression. The vascular effects of achieving other potential treatment targets, including the PsA Disease Activity Score (PASDAS) and the Disease Activity in PsA (DAPSA) score, remained uncertain. This study aimed to compare the vascular effects of achieving different treatment targets in PsA patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>This is a post hoc analysis of a 2\u2009year treat-to-target study aimed at MDA. A total of 101 consecutive PsA patients without overt cardiovascular disease were recruited. High-resolution carotid ultrasound and arterial stiffness markers were assessed annually. Low disease activity (LDA) was defined as MDA, DAPSA \u226414 or PASDAS \u22643.2. Sustained disease control was defined as achieving these targets at each visit from month 12 until month 24.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ninety patients [52 male (57.8%), age 50\u2009years (s.d. 11)] who completed 24 months of follow-up were included in this analysis. A total of 44%, 48% and 45% of patients achieved sustained DAPSA LDA (sDAPDA-LDA), sustained PASDAS LDA (sPASDAS-LDA) and sMDA, respectively. Patients who achieved sMDA had significantly less progression of carotid intima-media thickness than those who did not (P\u2009=\u20090.031). Using multivariate analysis, achieving sMDA and sPASDAS-LDA had a protective effect on plaque progression, less increase in total plaque area, reduced mean intima-media thickness and reduced augmentation index after adjusting for covariates. In contrast, no significant differences in the progression of vascular parameters were demonstrated between patients who did or did not achieve sDAPSA-LDA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Achieving sMDA\/sDASPAS-LDA, but not sDAPSA-LDA, was associated with a protective effect in subclinical atherosclerosis and arterial stiffness progression. A multidimensional domain of disease control might be better in minimizing cardiovascular risk in PsA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa025","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T12:07:29Z","timestamp":1578917249000},"page":"2881-2892","source":"Crossref","is-referenced-by-count":10,"title":["Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis\u2014which target should we choose?"],"prefix":"10.1093","volume":"59","author":[{"given":"Isaac T","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla C","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Yan","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac C","family":"Yim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tseung Kwan O Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy T","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tseung Kwan O Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley K","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty Y","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen Elizabeth Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tena K","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack J","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan P","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex P","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-8852","authenticated-orcid":false,"given":"Lai-Shan","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"2020092423550721400_keaa025-B1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","article-title":"Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis","volume":"76","author":"Schieir","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","article-title":"Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease","volume":"76","author":"Shen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology"},{"key":"2020092423550721400_keaa025-B4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3899\/jrheum.111334","article-title":"Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis \u2013 an inception cohort study","volume":"39","author":"Ajeganova","year":"2012","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1191\/1358863x06vm666ra","article-title":"Ultrasound-detected carotid plaque as a predictor of cardiovascular events","volume":"11","author":"Wyman","year":"2006","journal-title":"Vasc Med"},{"key":"2020092423550721400_keaa025-B7","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.160053","article-title":"Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis","volume":"43","author":"Ikdahl","year":"2016","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B10","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","article-title":"Subclinical carotid atherosclerosis in patients with psoriatic arthritis","volume":"59","author":"Tam","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/ATVBAHA.110.214585","article-title":"Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-alpha blockers and traditional disease-modifying antirheumatic drugs","volume":"31","author":"Di Minno","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020092423550721400_keaa025-B13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1136\/annrheumdis-2014-205267","article-title":"Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis","volume":"74","author":"Eder","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-015-0570-0","article-title":"Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study","volume":"17","author":"Shen","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2020092423550721400_keaa025-B15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death","volume":"41","author":"Gladman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/ard.2010.131359","article-title":"Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study","volume":"70","author":"Tam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.40366","article-title":"Association of tumor necrosis factor inhibitor treatment with reduced indices of subclinical atherosclerosis in patients with psoriatic disease","volume":"70","author":"Eder","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020092423550721400_keaa025-B18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2020092423550721400_keaa025-B19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/art.40695","article-title":"Effect of achieving minimal disease activity on the progression of subclinical atherosclerosis and arterial stiffness: a prospective cohort study in psoriatic arthritis","volume":"71","author":"Cheng","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2020092423550721400_keaa025-B20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.semarthrit.2017.10.021","article-title":"Considerations for the definition of remission criteria in psoriatic arthritis","volume":"47","author":"Mease","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","article-title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","article-title":"Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score","volume":"75","author":"Schoels","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3899\/jrheum.140172","article-title":"Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response","volume":"41","author":"Helliwell","year":"2014","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3899\/jrheum.150826","article-title":"Defining low disease activity states in psoriatic arthritis using novel composite disease instruments","volume":"43","author":"Coates","year":"2016","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3899\/jrheum.180249","article-title":"Comparison of different remission and low disease definitions in psoriatic arthritis and evaluation of their prognostic value","volume":"46","author":"Coates","year":"2019","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3899\/jrheum.170112","article-title":"Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: a cross-sectional analysis of a longitudinal cohort","volume":"44","author":"Lubrano","year":"2017","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3899\/jrheum.180267","article-title":"What should be the primary target of \u201ctreat to target\u201d in psoriatic arthritis?","volume":"46","author":"Coates","year":"2019","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2020092423550721400_keaa025-B31","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.semarthrit.2016.05.011","article-title":"Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis","volume":"46","author":"Shrestha","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.110792","article-title":"Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"39","author":"Hamdi","year":"2012","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1516-31802013000100020","article-title":"Carotid intima-media thickness in spondyloarthritis patients","volume":"131","author":"Skare","year":"2013","journal-title":"S\u00e3o Paulo Med J"},{"key":"2020092423550721400_keaa025-B35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3899\/jrheum.180195","article-title":"Using acute-phase reactants to inform the development of instruments for the updated psoriatic arthritis core outcome measurement set","volume":"46","author":"Elmamoun","year":"2019","journal-title":"J Rheumatol"},{"key":"2020092423550721400_keaa025-B36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2020092423550721400_keaa025-B37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.40366","article-title":"TNF-\u03b1 inhibitors are associated with reduced indices of subclinical atherosclerosis in patients with psoriatic disease","volume":"70","author":"Eder","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020092423550721400_keaa025-B38","doi-asserted-by":"crossref","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am J Hypertens"},{"key":"2020092423550721400_keaa025-B39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.2010.129379","article-title":"Development of a preliminary composite disease activity index in psoriatic arthritis","volume":"70","author":"Mumtaz","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092423550721400_keaa025-B41","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/art.40925","article-title":"The value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease","volume":"71","author":"Sobchak","year":"2019","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2881\/33790310\/keaa025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2881\/33790310\/keaa025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T03:56:46Z","timestamp":1601006206000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2881\/5748309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,2,22]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa025","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,2,22]]}}}